Publications by authors named "Caleb Stein"

Claim this Profile
A
An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden.
Erin W Meermeier, Kirsten Pfeffer, Caleb K Stein, Meaghen E Sharik, Megan T Du

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans.
Francesco Maura, David G Coffey, Caleb K Stein, Esteban Braggio, Bachisio Ziccheddu

Nat Commun· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Classification and Individualized Prognosis in Multiple Myeloma.
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Caleb Stein

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma.
Natthakan Thongon, Feiyang Ma, Natalia Baran, Pamela Lockyer, Jintan Liu, Caleb Stein

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma.
Seth J Welsh, Benjamin G Barwick, Erin W Meermeier, Daniel L Riggs, Chang-Xin Shi, Caleb K Stein

Blood Cancer Discov· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma.
Paola Neri, Benjamin G Barwick, David Jung, Jonathan C Patton, Ranjan Maity, Caleb K Stein

Blood Cancer Discov· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Vk*MYC Mouse Model recapitulates human multiple myeloma evolution and genomic diversity.
Francesco Maura, David G Coffey, Caleb K Stein, Esteban Braggio, Bachisio Ziccheddu

bioRxiv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor burden limits bispecific antibody efficacy through T cell exhaustion averted by concurrent cytotoxic therapy.
Erin W Meermeier, Seth J Welsh, Meaghen E Sharik, Megan T Du, Victoria M Garbitt, Caleb K Stein

Blood Cancer Discov· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monosomic loss of MIR15A/MIR16-1 is a driver of multiple myeloma proliferation and disease progression.
Marta Chesi, Caleb K Stein, Victoria M Garbitt, Meaghen E Sharik, Yan W Asmann

Blood Cancer Discov· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of PIKfyve kinase as a target in multiple myeloma.
Cecilia Bonolo de Campos, Yuan Xiao Zhu, Nikolai Sepetov, Sergei Romanov, Laura Ann Bruins, Caleb K Stein

Haematologica· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC dysregulation in the progression of multiple myeloma.
Kristine Misund, Niamh Keane, Caleb K Stein, Yan W Asmann, Grady Day

Leukemia· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Presentation and Gene Expression Profiling of Immunoglobulin M Multiple Myeloma Compared With Other Myeloma Subtypes and Waldenström Macroglobulinemia.
Shebli Atrash, Qing Zhang, Xenofon Papanikolaou, Caleb Stein, Al-Ola Abdallah

J Glob Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma.
Leo Rasche, Edgardo Angtuaco, James E McDonald, Amy Buros, Caleb Stein, Joshua Epstein

Blood· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Search for rare protein altering variants influencing susceptibility to multiple myeloma.
Matthew Scales, Daniel Chubb, Sara E Dobbins, David C Johnson, Ni Li, Caleb Stein

Oncotarget· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma.
Caleb K Stein, Charlotte Pawlyn, Shweta Chavan, Leo Rasche, Niels Weinhold

Oncotarget· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.
Niels Weinhold, Cody Ashby, Leo Rasche, Shweta S Chavan, Caleb Stein, Joshua Epstein

Blood· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Removing batch effects from purified plasma cell gene expression microarrays with modified ComBat.
Caleb K Stein, Pingping Qu, Joshua Epstein, Amy Buros, Adam Rosenthal

BMC Bioinformatics· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis.
Xenofon Papanikolaou, Sarah Johnson, Tarun Garg, Erming Tian, Ruslana Tytarenko, Caleb Stein, Joshua Epstein

Oncotarget· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis